HistoIndex to Debut FibroSIGHT™ Plus and Showcase Latest Scientific Findings at AASLD The Liver Meeting® 2025 SINGAPORE, Oct. 15, 2025 /PRNewswire/ — HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, is returning to The Liver Meeting® (TLM) 2025, hosted by the American Association for the Study of Liver Diseases (AASLD). The conference, which […]
HistoIndex Marks Another Step Forward with FibroSIGHT™ Plus: Introducing AI-based Quantitative Analysis in Fibrosis Assessment SINGAPORE, Aug. 10, 2025 /PRNewswire/ — HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, has announced the launch of FibroSIGHT™ Plus, its second Laboratory Developed Test (LDT) available in the United States. Building on the foundation of FibroSIGHT™[1], which debuted
HistoIndex Secures SGD 9 Million Investment to Drive Next Phase of Expansion SINGAPORE, May 2, 2025 /PRNewswire/ — HistoIndex, known for its groundbreaking biophotonic Second Harmonic Generation (SHG) technology and a pioneering leader in Artificial Intelligence (AI) digital pathology for the management of fibrotic diseases, has announced the close of a S$9 million investment round to support its next
HistoIndex Secures SGD9 Million Investment to Drive Next Phase of Expansion Read More »
A New Standard in Clinical Care for MASH Patients: HistoIndex Launches FibroSIGHT™ SINGAPORE, March 17, 2025 /PRNewswire/ — HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the launch of their first Laboratory Developed Test (LDT) FibroSIGHT™ – now available in the United States. This marks a significant milestone
A New Standard in Clinical Care for MASH Patients: HistoIndex Launches FibroSIGHT™ Read More »
BRIDGING CLINICAL RESEARCH AND CLINICAL CARE WITH AI-AIDING PATHOLOGISTS TOOL SINGAPORE, Dec. 9, 2024 /PRNewswire/ — A newly published collaborative study[1] in the Journal of Hepatology, featuring HistoIndex – a global leader in stain-free digital pathology solutions for managing fibrotic diseases – alongside Merck & Co., MSD, Virginia Commonwealth University (VCU), The National Institutes of Health (NIH) and a panel of distinguished international
Bridging Clinical Research and Clinical Care with AI-aiding Pathologists Tool Read More »
©2026 Histoindex Pte Ltd. All Rights Reserved. All logos and trademarks are the property of HistoIndex or their respective owners.